Vertex Pharmaceuticals (Canada) Inc.
Registration:
2
of
2
(2020-05-04
to
2020-12-31)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Vertex Pharmaceuticals has developed a portfolio of drug therapies that treat the root causes of cystic fibrosis, and is seeking to have these medicines listed on B.C.'s Pharmacare formularly.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|